API Holdings (Pharmeasy)

Pharmeasy Share Price Full Details About the Company

PharmEasy is India's leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products, and services from registered and trusted pharmacies, leading diagnostic laboratories, and trusted doctors across India, serving every habitable zip code of the country. The journey of PharmEasy was started in 2015, when founders Dharmil Sheth, an MBA from IMT Ghaziabad and Dr. Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, came up with the idea of an online pharmacy to make healthcare affordable and accessible to one and all.

Overview of PharmEasy

They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. They operate an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages A. providing digital tools and information on illness and wellness.

B. Offering Teleconsultation.

C. Offering diagnostics and Radiology tests.

D. delivering treatment protocols including products and devices. PharmEasy custom-built proprietary technology, unified data platforms, supply chain capabilities, and a deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.

These capabilities enable PharmEasy to provide each stakeholder in the healthcare value-chain, viz.: (a) channel (wholesalers, retailers, and chemists/institutions). (b) consultants (and hospitals), diagnostic and radiology labs. (c) consumers (d) companies (pharmaceutical, nutraceutical,medical devices.



The businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing the ability to provide access in an affordable manner to the common man. The platforms have scaled across urban, semi-urban, and rural India, with an ability to serve people across income groups and geographies.

Journey of PharmEasy 

2015 - Started the journey in Mumbai and received angel funding.

2016 - Received Series-A funding and expanded into 5 cities. The same year they have started a home-diagnostics service.

2017 - Received Series-B funding and expanded into 700 cities. Launched online delivery of health care products.

2018 - Received Series-C funding and expanded PAN India presence.

2019 - Received Series-D funding and expanded more than 22000+ PIN codes.

2020- It has got merged with Ascent Health and 5 other companies to form API Holdings, to form India’s biggest online healthcare company.

2021 - It has purchased 66% stakes in Thyrocare and this is the first listed company to be acquired by any Unicorn in India. Currently, there is a team of 4000+ dedicated employees and have more than 10000+ retail stores working 24*7 to ensure medicines are delivered on time and at the best possible prices.

Funding History